Patent applications and USPTO patent grants for EMCURE PHARMACEUTICALS LIMITED.The latest application filed is for "carmustine formulation".
Patent | Date |
---|---|
Carmustine Formulation App 20210361599 - Gondaliya; Deepak Pragjibhai ;   et al. | 2021-11-25 |
Stable Ready-to-use Carmustine Pharmaceutical Composition App 20210322304 - Pramanick; Sougata ;   et al. | 2021-10-21 |
Kit For Preparing Injectable Carmustine Solutions App 20210038543 - Gondaliya; Deepak Pragjibhai ;   et al. | 2021-02-11 |
Process for preparation of isoproterenol hydrochloride Grant 10,759,738 - Gurjar , et al. Sep | 2020-09-01 |
Kit For Preparing Injectable Carmustine Solutions App 20200108010 - Gondaliya; Deepak Pragjibhai ;   et al. | 2020-04-09 |
Lipid formulations of carmustine Grant 10,583,101 - Gondaliya , et al. | 2020-03-10 |
Process for preparation of prostacyclin derivatives Grant 10,556,851 - Gurjar , et al. Feb | 2020-02-11 |
Process for preparation of trientine dihydrochloride Grant 10,508,075 - Gurjar , et al. Dec | 2019-12-17 |
Process For Preparation Of Isoproterenol Hydrochloride App 20190367443 - GURJAR; Mukund Keshav ;   et al. | 2019-12-05 |
Process For Preparation Of Icatibant Acetate App 20190309014 - Gurjar; Mukund Keshav ;   et al. | 2019-10-10 |
Lipid Formulations Of Carmustine App 20190298671 - Gondaliya; Deepak Pragjibhai ;   et al. | 2019-10-03 |
Sterile Parenteral Suspensions App 20190269616 - Pramanick; Sougata ;   et al. | 2019-09-05 |
Liquid formulation of cabazitaxel Grant 10,278,946 - Patel , et al. | 2019-05-07 |
Process For Preparation Of Prostacyclin Derivatives App 20190031589 - Gurjar; Mukund Keshav ;   et al. | 2019-01-31 |
Derivatives Of Pyrroloimidazole Or Analogues Thereof Which Are Useful For The Treatment Of Inter Alia Cancer App 20190031665 - GURJAR; Mukund Keshav ;   et al. | 2019-01-31 |
Liquid Formulation Of Cabazitaxel App 20180311203 - PATEL; Hiren Pravinbhai ;   et al. | 2018-11-01 |
An Improved Process For Preparation Of Trientine Dihydrochloride App 20180265451 - GURJAR; Mukund ;   et al. | 2018-09-20 |
Liquid Formulation Of Cabazitaxel App 20180185323 - PATEL; Hiren Pravinbhai ;   et al. | 2018-07-05 |
Process for preparation of acitrecin Grant 9,919,993 - Gurjar , et al. March 20, 2 | 2018-03-20 |
Process For Preparation Of Acitrecin App 20170275229 - KESHAV; Gurjar Mukund ;   et al. | 2017-09-28 |
Fingolimod hydrochloride process Grant 9,643,914 - Gurjar , et al. May 9, 2 | 2017-05-09 |
Pyridone derivatives as acid secretion inhibitors and process for preparation thereof Grant 9,522,924 - Gurjar , et al. December 20, 2 | 2016-12-20 |
Pyridone Derivatives As Acid Secretion Inhibitors And Process For Preparation Thereof App 20160355529 - Gurjar; Mukund Keshav ;   et al. | 2016-12-08 |
Controlled release formulations of nisoldipine Grant 9,480,681 - Baweja , et al. November 1, 2 | 2016-11-01 |
Synthesis Of Raltegravir App 20160311810 - Gurjar; Mukund Keshav ;   et al. | 2016-10-27 |
Synthesis of Raltegravir Grant 9,475,799 - Gurjar , et al. October 25, 2 | 2016-10-25 |
Fingolimod Hydrochloride Process App 20160289166 - GURJAR; Mukund K. ;   et al. | 2016-10-06 |
Pyridone derivatives as acid secretion inhibitors and process for preparation thereof Grant 9,447,094 - Gurjar , et al. September 20, 2 | 2016-09-20 |
Synthesis of raltegravir Grant 9,403,809 - Gurjar , et al. August 2, 2 | 2016-08-02 |
Pyridone Derivatives As Acid Secretion Inhibitors And Process For Preparation Thereof App 20150232467 - Gurjar; Mukund Keshav ;   et al. | 2015-08-20 |
Process for preparation of zolmitriptan Grant 9,006,453 - Gurjar , et al. April 14, 2 | 2015-04-14 |
Synthesis Of Raltegravir App 20150045554 - Gurjar; Mukund Keshav ;   et al. | 2015-02-12 |
Rilpivirine process Grant 8,952,155 - Gurjar , et al. February 10, 2 | 2015-02-10 |
Process for the preparation of melphalan hydrochloride Grant 8,921,596 - Gurjar , et al. December 30, 2 | 2014-12-30 |
Controlled Release Formulations of Nisoldipine App 20140341990 - Baweja; Jitendra Mohansingh ;   et al. | 2014-11-20 |
Rilpivirine Process App 20140275538 - Gurjar; Mukund Keshav ;   et al. | 2014-09-18 |
Process For Preparation Of Zolmitriptan App 20140228582 - Gurjar; Mukund Keshav ;   et al. | 2014-08-14 |
Process for preparation of taxane derivatives Grant 8,686,165 - Gurjar , et al. April 1, 2 | 2014-04-01 |
Process for the preparation of Efavirenz Grant 8,604,189 - Gurjar , et al. December 10, 2 | 2013-12-10 |
Process for preparation of benzphetamine and its pharmaceutically acceptable salts Grant 8,569,544 - Gurjar , et al. October 29, 2 | 2013-10-29 |
Process for producing enantiomer of amlodipine in high optical purity Grant 8,445,688 - Gharpure , et al. May 21, 2 | 2013-05-21 |
Sustained release formulation of alprazolam Grant 8,277,840 - Joshi , et al. October 2, 2 | 2012-10-02 |
Cost-effective process for preparation of manufacture of iron sucrose Grant 8,030,480 - Gharpure , et al. October 4, 2 | 2011-10-04 |
Process for Preparation of Taxane Derivatives App 20110105598 - GURJAR; Mukund K. ;   et al. | 2011-05-05 |
Process For Preparation Of Benzphetamine And Its Pharmaceutically Acceptable Salts App 20110046416 - Gurjar; Mukund K. ;   et al. | 2011-02-24 |
Process For Producing Enantiomer Of Amlodipine In High Optical Purity App 20110021783 - GHARPURE; Milind Moreshwar ;   et al. | 2011-01-27 |
Process for producing enantiomer of amlodipine in high optical purity Grant 7,858,801 - Gharpure , et al. December 28, 2 | 2010-12-28 |
Cost-effective Process For Preparation Of Manufacture Of Iron Sucrose App 20090299052 - Gharpure; Milind Moreshwar ;   et al. | 2009-12-03 |
Process for Producing Enantiomer of Amlodipine in High Optical Purity App 20080262239 - Gharpure; Milind Moreshwar ;   et al. | 2008-10-23 |
Process for producing atenolol of high optical purity Grant 6,982,349 - Mehta , et al. January 3, 2 | 2006-01-03 |
NCAGE Code | 3604Y | EMCURE PHARMACEUTICALS LIMITED |
CAGE Code | 3604Y | EMCURE PHARMACEUTICALS LIMITED |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.